Evidence map›Paper›PMID 40599036›Full record

ArticleANZ journal of surgery2025

Re-Exploration Carpal Tunnel Surgery for Iatrogenic Median Nerve Injuries.

Vicki McClure, Jieyun Zhou, Scott Ferris

Abstract readCase Reports
In one paragraph

Article in ANZ journal of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vicki McClureAlfred Health, Plastic and Reconstructive Surgery Unit, Melbourne, Victoria, Australia.ORCID 0000-0002-6933-3351
Jieyun ZhouAlfred Health, Plastic and Reconstructive Surgery Unit, Melbourne, Victoria, Australia.
Scott FerrisAlfred Health, Plastic and Reconstructive Surgery Unit, Melbourne, Victoria, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarpal tunnel syndrome (CTS) is the most prevalent peripheral nerve entrapment disorders of the upper limb worldwide, making carpal tunnel release (CTR) one of the most frequently performed procedures. While CTR is typically successful, a small but important subset of patients may experience failure of the initial surgery, presenting with persistent, recurrent, or new symptoms that may necessitate re-exploration. CASE REPORT: This case series details four patients who were referred to a single Plastic Surgeon in Melbourne Australia, with concerning new or persistent symptoms following initial CTR. For each patient, the primary CTR was indicated due to severe, unrelieved symptoms of CTS that were refractory to conservative treatment. DISCUSSION: CTR is generally a highly effective procedure with positive outcomes for most patients. However, in some cases, symptoms can remain unresolved or may even worsen postoperatively. Prompt identification and referral of these patients are crucial to achieve optimal outcomes. For those whose symptoms persist or worsen, exploratory surgery may be indicated for two primary reasons: (1) an incomplete release is suspected, or (2) injury to the median or palmar cutaneous nerve is likely. When exploratory surgery is considered, it should ideally be performed by a reconstructive microsurgeon. Early referral post-CTR is essential, enabling timely re-exploration and, if necessary, simultaneous definitive reconstruction, thereby improving the likelihood of successful resolution of symptoms.

Indexed as

Carpal Tunnel SyndromeDecompression, SurgicalMedian NerveHumansIatrogenic DiseaseReoperationTreatment Outcomecarpal tunnel releasecarpal tunnel syndromeCTRCTSiatrogenic nerve injuryincomplete CTRmedian nerve injury

Identifiers

PMID40599036
PMCPMC12571955

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.